Understanding genetic analysis for breast cancer and its implications for plastic surgery

Aesthetic Surgery Journal

Volumn 28, Issue 1, 2008, Pages 85-91

  Soltanian, Hooman ^a   Okada, Haruko ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BIOPSY; BREAST CANCER; BREAST RECONSTRUCTION; CANCER RISK; DECISION MAKING; ESTHETICS; GENETIC ANALYSIS; GENETIC COUNSELING; HIGH RISK PATIENT; HUMAN; MASTECTOMY; MEDICAL INFORMATION; MUTATION; NIPPLE; ONCOGENE; ONCOLOGY; PLASTIC SURGERY; PRIORITY JOURNAL; SKIN; SURGEON; TREATMENT PLANNING;

ALGORITHMS; BREAST IMPLANTS; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MAMMAPLASTY; MAMMOGRAPHY; MASTECTOMY; MUTATION; RISK ASSESSMENT;

EID: 39049119192     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1016/j.asj.2007.10.002     Document Type: Article

References (52)

1. Surveillance Epidemiology and End Results. (Accessed 8/27/2007, at http://seer.cancer.gov/statfacts/html/breast.html.)
2. Pharoah P., Day N., Duffy S., Easton D., and Ponder B. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71 (1997) 800-809
3. Antoniou A., Pharoah P., Narod S., Risch H., Eyfjord J., Hopper J., et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72 (2003) 1117-1130
4. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74 (2004) 1175-1182
5. Jasin M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 21 (2002) 8981-8993
6. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 143 (2005) 355-361
7. Frank T., Deffenbaugh A., Reid J., Hulick M., Ward B., Lingenfelter B., et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20 (2002) 1480-1490
8. Hoskins K., Zwaagstra A., and Ranz M. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer 107 (2006) 1769-1776
9. Gail M., Brinton L., Byar D., Corle D., Green S., Schairer C., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81 (1989) 1879-1886
10. Lawrence W., Peshkin B., Liang W., Isaacs C., Lerman C., and Mandelblatt J. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. Cancer Epidemiol Biomarkers Prev 10 (2001) 475-481
11. State Anti-Discrimination Laws. (Accessed 9/3/2007, at http://www.ncsl.org/programs/health/genetics/ndishlth.htm.)
12. Wood M., Mullineaux L., Rahm A., Fairclough D., and Wenzel L. Impact of BRCA1 testing on women with cancer: a pilot study. Genet Test 4 (2000) 265-272
13. Lodder L., Frets P., Trijsburg R., Meijers-Heijboer E., Klijn J., Seynaeve C., et al. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 73 (2002) 97-112
14. Genetic/Familial High Risk Assessment: Breast and Ovarian. (Accessed at http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf.)
15. Saslow D., Boetes C., Burke W., Harms S., Leach M., Lehman C., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57 (2007) 75-89
16. Rubin S., Benjamin I., Behbakht K., Takahashi H., Morgan M., LiVolsi V., et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med 335 (1996) 1413-1416
17. Pharoah P., Easton D., Stockton D., Gayther S., and Ponder B. Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group. Cancer Res 59 (1999) 868-871
18. Lakhani S., Manek S., Penault-Llorca F., Flanagan A., Arnout L., Merrett S., et al. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res 10 (2004) 2473-2481
19. Spear S., Carter M., and Schwarz K. Prophylactic mastectomy: indications, options, and reconstructive alternatives. Plast Reconstr Surg 115 (2005) 891-909
20. Osin P., Crook T., Powles T., Peto J., and Gusterson B. Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers. Lancet 351 9114 (1998) 1487
21. Hartmann L., Schaid D., Woods J., Crotty T., Myers J., Arnold P., et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340 (1999) 77-84
22. Hartmann L., Sellers T., Schaid D., Frank T., Soderberg C., Sitta D., et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93 (2001) 1633-1637
23. Hatcher M., Fallowfield L., and A'Hern R. The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ 322 7278 (2001) 76
24. Geiger A., Nekhlyudov L., Herrinton L., Rolnick S., Greene S., West C., et al. Quality of life after bilateral prophylactic mastectomy. Ann Surg Oncol 14 (2007) 686-694
25. Metcalfe K., Lynch H., Ghadirian P., Tung N., Olivotto I., Warner E., et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22 (2004) 2328-2335
26. Schwartz M., Lerman C., Brogan B., Peshkin B., Halbert C., DeMarco T., et al. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 22 (2004) 1823-1829
27. Frost M., Schaid D., Sellers T., Slezak J., Arnold P., Woods J., et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284 (2000) 319-324
28. Rebbeck T., Lynch H., Neuhausen S., Narod S., Van't Veer L., Garber J., et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346 (2002) 1616-1622
29. Toth B., and Lappert P. Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning. Plast Reconstr Surg 87 (1991) 1048-1053
30. Ho C., Mak C., Lau Y., Cheung W., Chan M., and Hung W. Skin involvement in invasive breast carcinoma: safety of skin-sparing mastectomy. Ann Surg Oncol 10 (2003) 102-107
31. Carlson G., Styblo T., Lyles R., Bostwick J., Murray D., Staley C., et al. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism?. Ann Surg Oncol 10 (2003) 108-112
32. Cunnick G., and Mokbel K. Skin-sparing mastectomy. Am J Surg 188 (2004) 78-84
33. Simmons R., Fish S., Gayle L., La Trenta G., Swistel A., Christos P., et al. Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies. Ann Surg Oncol 6 (1999) 676-681
34. Bleicher R., Hansen N., and Giuliano A. Skin-sparing mastectomy. Specialty bias and worldwide lack of consensus. Cancer 98 (2003) 2316-2321
35. Laronga C., Kemp B., Johnston D., Robb G., and Singletary S. The incidence of occult nipple-areola complex involvement in breast cancer patients receiving a skin-sparing mastectomy. Ann Surg Oncol 6 (1999) 609-613
36. Simmons R., Brennan M., Christos P., King V., and Osborne M. Analysis of nipple/areolar involvement with mastectomy: can the areola be preserved?. Ann Surg Oncol 9 (2002) 165-168
37. Gerber B., Krause A., Reimer T., Muller H., Kuchenmeister I., Makovitzky J., et al. Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure. Ann Surg 238 (2003) 120-127
38. Crowe Jr. J., Kim J., Yetman R., Banbury J., Patrick R., and Baynes D. Nipple-sparing mastectomy: technique and results of 54 procedures. Arch Surg 139 (2004) 148-150
39. Sufi P., Gittos M., and Collier D. Envelope mastectomy with immediate reconstruction (EMIR). Eur J Surg Oncol 26 (2000) 367-370
40. Mosahebi A., Ramakrishnan V., Gittos M., and Collier J. Aesthetic outcome of different techniques of reconstruction following nipple-areola-preserving envelope mastectomy with immediate reconstruction. Plast Reconstr Surg 119 (2007) 796-803
41. Cathcart III R., and Hagerty R. Preoperative and postoperative considerations in elective breast operations. Ann Plast Surg 22 (1989) 533-538
42. Perras C. Fifteen years of mammography in cosmetic surgery of the breast. Aesthetic Plast Surg 14 (1990) 81-84
43. Colwell A., Kukreja J., Breuing K., Lester S., and Orgill D. Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience. Plast Reconstr Surg 113 (2004) 1984-1988
44. Hage J., and Karim R. Risk of breast cancer among reduction mammaplasty patients and the strategies used by plastic surgeons to detect such cancer. Plast Reconstr Surg 117 (2006) 727-735 discussion 736.
45. Beer G., Kompatscher P., and Hergan K. Diagnosis of breast tumors after breast reduction. Aesthetic Plast Surg 20 (1996) 391-397
46. Brown F., Sargent S., Cohen S., and Morain W. Mammographic changes following reduction mammaplasty. Plast Reconstr Surg 80 (1987) 691-698
47. Miglioretti D., Rutter C., Geller B., Cutter G., Barlow W., Rosenberg R., et al. Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA 291 (2004) 442-450
48. Steiner D., Schwager R., and Lewittes D. Effects of breast augmentation on accuracy of mammography. JAMA 291 (2004) 2073 author reply 2074.
49. Jakubietz M., Janis J., Jakubietz R., and Rohrich R. Breast augmentation: cancer concerns and mammography-a literature review. Plast Reconstr Surg 113 (2004) 117e-122e
50. Tarone R., Lipworth L., Young V., and McLaughlin J. Breast reduction surgery and breast cancer risk: does reduction mammaplasty have a role in primary prevention strategies for women at high risk of breast cancer?. Plast Reconstr Surg 113 (2004) 2104-2110 discussion 2111-2112.
51. Woerdeman L., Hage J., Hofland M., and Rutgers E. A prospective assessment of surgical risk factors in 400 cases of skin-sparing mastectomy and immediate breast reconstruction with implants to establish selection criteria. Plastic Reconstr Surg 119 (2007) 455-463
52. Zienowicz R., and Karacaoglu E. Implant-based breast reconstruction with allograft. Plastic Reconstr Surg 120 (2007) 373-381